Open Label Study Investigating the Efficacy and Safety of Roxadustat for Treatment of Anemia in Patients Receiving Chemotherapy Treatment for Non-Myeloid Malignancies

Open Label Study Investigating the Efficacy and Safety of Roxadustat for Treatment of Anemia in Patients Receiving Chemotherapy Treatment for Non-Myeloid Malignancies
Recruiting
18 years - 99 years
All
Phase 2
24 participants needed
1 Location

Brief description of study

The main purpose of this study is to find out if the experimental drug roxadustat (also known as FG-4592) is safe and effective for potentially treating anemia in people receiving chemotherapy treatments for cancer.

In order to take part in this study, participant must have anemia (as confirmed by a blood test), and must have received a few chemotherapy treatments, which the study doctor thinks is the cause of anemia. Participant must also meet other study requirements to qualify for the study.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: cancer,anemia
  • Age: 18 years - 99 years
  • Gender: All


Updated on 04 Aug 2024. Study ID: 834078

Find a site

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Race
Ethnicity
Other language

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center